Food and Drug Administration public hearing on the draft guidance for exception from informed consent requirements for emergency research: testimony of Novo Nordisk.
Weiskopf
Richard B
RB
Research & Development, Novo Nordisk A/S, Bagsvaerd, Denmark. rwes@novonordisk.com
D035843:Biomedical Research / Q000592:standards*; D002986:Clinical Trials as Topic / Q000592:standards*; D003718:Denmark; D004345:Drug Industry; D004635:Emergency Medicine; D032984:Ethics, Research; D017408:Guidelines as Topic; D006801:Humans; D007258:Informed Consent; D014481:United States; D014486:United States Food and Drug Administration